Trospium chloride: IDEV completed enrollment of 524 patients in a double-blind, placebo-controlled U.S. Phase III trial of its trospium chloride to treat overac

Indevus Pharmaceuticals Inc. (INDV), Lexington, Mass. Product: Trospium chloride Business: Urological Therapeutic category: Receptor antagonist Target: Muscarinic receptors Description: Muscarinic re...